Hims & Hers Expands to Europe – Acquisition of ZAVA as a Strategic Growth Lever

Reading Time: 3 minutes
Telemedicine provider Hims & Hers acquires ZAVA, a central platform for entering the European healthcare market. New margin opportunities arise through personalized obesity therapies in the UK Hims & Hers Health (NYSE: HIMS) has set a clear course for international expansion with the announced acquisition of the European telemedicine platform ZAVA. The transaction is considered a milestone for the US company, which specializes in digitized, personalized healthcare – particularly in areas such as dermatology, sexual health,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.